Crystalline Management Inc.
- SEC CIK
- 0001891834
- Latest filing
- Nov 8, 2024
The latest 13F from Crystalline Management Inc. covers Q3 2024 (filed Nov 8, 2024): 72 long positions worth $97.1M. The top 10 holdings make up 63.6% of the portfolio, and the largest is Chefs Whse Inc at 9.1%. Livermore has 8 filings on Form 13F from this institution, going back to Q4 2022.
What changed in Q3 2024
Share counts compared with Q2 2024: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 29
- Est. +$52.3M
- Added
- 3
- Est. +$4.37M
- Reduced
- 8
- Est. −$3.72M
- Sold out
- 40
- Est. −$46.8M
Top 5 holdings
Share of this quarter's portfolio value
- Chefs Whse Inc163086AE19.1%$8.86M
- Integer Hldgs Corp45826HAB58.2%$7.95M
- Altair Engr Inc021369AC78.1%$7.86M
- HubSpot Inc443573AD27.8%$7.54M
- Post Hldgs Inc737446AT17.4%$7.17M
Biggest buys
New and added positions, by estimated amount bought
- Chefs Whse Inc163086AE1+$8.86MNew
- HubSpot Inc443573AD2+$7.54MNew
- Envestnet, Inc.29404KAE6+$5.45MNew
- Ford MTR Co Del345370CZ1+$4.89MNew
- GATOGatos Silver, Inc.
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Chefs Whse Inc163086AE1+9.12 pp0.0% → 9.1%
- HubSpot Inc443573AD2+7.77 pp0.0% → 7.8%
- Envestnet, Inc.29404KAE6+5.61 pp0.0% → 5.6%
- Ford MTR Co Del345370CZ1+5.04 pp0.0% → 5.0%
- GATOGatos Silver, Inc.
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q3 2024, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $97.1M
- +$10.5M (+12.1%) vs. prior quarter
- Positions
- 72
- −11 vs. prior quarter
- Top 10 concentration
- 63.6%
- Top 10 as share of value
- Turnover
- 55.0%
- Q3 2024, one quarter
- Average holding period
- 2.2 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2022), so positions held before then are understated.
13F filings by quarter
8 quarters, going back to Q4 2022. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $198.4M (Q4 2022)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q3 2024 | Nov 8, 2024 | 72 | $97.1M | Chefs Whse IncInteger Hldgs CorpAltair Engr Inc | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 8, 2024 | 83 | $86.6M | Veeco Instrs Inc DelAltair Engr IncPost Hldgs Inc | vs. Q1 2024 | SEC |
| Q1 2024 | May 10, 2024 | 91 | $76.7M | Altair Engr IncEnerplus CorpInteger Hldgs Corp | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 12, 2024 | 89 | $79.0M | Penn Natl Gaming IncSplunk IncNFYS | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 13, 2023 | 121 | $131.1M | DENNEWRPenn Natl Gaming Inc | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 9, 2023 | 129 | $141.3M | Penn Natl Gaming IncUNVRCentennial Resource Dev Inc | vs. Q1 2023 | SEC |
| Q1 2023 | May 9, 2023 | 109 | $129.3M | Centennial Resource Dev IncGLAUKOS CorpSquare Inc | vs. Q4 2022 | SEC |
| Q4 2022 | Mar 13, 2023 | 140 | $198.4M | UMPQNovavax IncMeridian Bioscience Inc | – | SEC |